Aug 3, 2026 06:59AM
Jul 28, 2026 08:02AM
Jul 13, 2026 08:01AM
Jun 24, 2026 08:02AM
Jun 15, 2026 08:03AM
Jun 1, 2026 08:00AM
May 15, 2026 04:17PM Enlivex receives Nasdaq minimum bid price deficiency notice
Apr 30, 2026 08:33AM
Apr 8, 2026 08:31AM
Apr 7, 2026 07:44AM
Mar 26, 2026 08:31AM
Mar 24, 2026 09:28AM
Mar 20, 2026 09:00AM
Feb 9, 2026 02:30PM RedChip Fintech & DATS Conference Replays Now Available Featuring Public Companies Shaping the Future of Digital Finance
Jan 27, 2026 09:35AM
Jan 27, 2026 09:35AM
Jan 23, 2026 08:01AM
Jan 12, 2026 06:51AM
Nov 24, 2025 10:42AM
Oct 3, 2025 09:00AM
Sep 19, 2025 09:00AM Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Sep 15, 2025 07:38AM
Sep 11, 2025 08:01AM
Aug 18, 2025 07:48AM
Jun 13, 2025 10:00AM
Apr 24, 2025 07:10AM
Mar 24, 2025 06:42AM
Mar 3, 2025 08:23AM Enlivex (ENLV) Announces Positive Interim Data – Statistically Significant 47.0% Durable and Persistent Pain Reduction At Six Months, in Patients with Moderate to Severe Knee Osteoarthritis
Feb 18, 2025 06:33AM
Feb 11, 2025 02:30PM
Jan 10, 2025 09:00AM
Nov 26, 2024 10:15AM
Sep 27, 2024 06:51AM
Sep 26, 2024 12:14PM
Sep 9, 2024 06:43AM H.C. Wainwright Reiterates Buy Rating on Enlivex Therapeutics (ENLV)
Aug 30, 2024 09:00AM
Aug 27, 2024 07:05AM
Jul 19, 2024 09:00AM
Jun 11, 2024 06:42AM

427,666 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All